Claudia Llinas del Torrent

Claudia Llinas del Torrent

Auto-generated profile, based on publicly available information

Claudia Llinas del Torrent

Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2024 in Nature
Verified
Journal Article
Closed access
PDF file
Claire Alice de MarchClaire Alice de March
Claire Alice de March
NMNing Ma
Ning Ma
CBChristian B. Billesbølle
Christian B. Billesbølle
JTJeevan Tewari
Jeevan Tewari
CTClaudia Llinas del Torrent
Claudia Llinas del Torrent
HMHiroaki Matsunami
Hiroaki Matsunami

8 October 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ALAijun Liu
Aijun Liu
YLYezhou Liu
Yezhou Liu
CMClàudia Llinàs del Torrent Masachs
Clàudia Llinàs del Torrent Masachs
WZWeijia Zhang
Weijia Zhang
LPLeonardo Pardo
Leonardo Pardo
RYRichard Ye
Richard Ye
Kaposi’s sarcoma-associated herpesvirus (KSHV) encodes a viral G protein-coupled receptor, KSHV-GPCR, that contributes to KSHV immune evasion and pathogenesis of Kaposi’s sarcoma. KSHV-GPCR shares a high similarity with CXC chemokine receptors CXCR2 and can be activated by selected chemokine ligands. Like other herpesvirus-encoded GPCRs, KSHV-GPCR is characterized by its constitutive activity by coupling to various G proteins. We investigated the structural basis of ligand-dependent and constitutive activation of KSHV-GPCR, obtaining high-resolution cryo-EM structures of KSHV-GPCR–Gi complexes with and without the bound CXCL1 chemokine. Analysis of the apo-KSHV-GPCR–Gi structure (2.81 Å) unraveled the involvement of extracellular loop 2 in constitutive activation of the receptor. In comparison, the CXCL1-bound KSHV-GPCR–Gi structure (3.01 Å) showed a two-site binding mode and provided detailed information of CXCL1 binding to a chemokine receptor. The dual activation mechanism employed by KSHV-GPCR represents an evolutionary adaptation for immune evasion and contributes to the pathogenesis of Kaposi’s sarcoma. Together with results from functional assays that confirmed the structural models, these findings may help to develop therapeutic strategies for KSHV infection.

23 July 2024 in British Journal of Pharmacology
Verified
Journal Article
Open access
CTClaudia Llinas del Torrent
Claudia Llinas del Torrent
IRIu Raïch
Iu Raïch
AGAngel Gonzalez
Angel Gonzalez
JLJaume Lillo
Jaume Lillo
NCNil Casajuana‐Martin
Nil Casajuana‐Martin
GNGemma Navarro
Gemma Navarro
Background and Purpose: Allosterism is a regulatory mechanism for GPCRs that can be attained by ligand‐binding or protein–protein interactions with another GPCR. We have studied the influence of the dimer interface on the allosteric properties of the A2A receptor and CB2 receptor heteromer.Experimental Approach: We have evaluated cAMP production, phosphorylation of signal‐regulated kinases (pERK1/2), label‐free dynamic mass redistribution, β‐arrestin 2 recruitment and bimolecular fluorescence complementation assays in the absence and presence of synthetic peptides that disrupt the formation of the heteromer. Molecular dynamic simulations provided converging evidence that the heteromeric interface influences the allosteric properties of the A2AR–CB2R heteromer.Key Results: Apo A2AR blocks agonist‐induced signalling of CB2R. The disruptive peptides, with the amino acid sequence of transmembrane (TM) 6 of A2AR or CB2R, facilitate CB2R activation, suggesting that A2AR allosterically prevents the outward movement of TM 6 of CB2R for G protein binding. Significantly, binding of the selective antagonist SCH 58261 to A2AR also facilitated agonist‐induced activation of CB2R.Conclusions and Implications: It is proposed that the A2AR–CB2R heteromer contains distinct dimerization interfaces that govern its functional properties. The molecular interface between protomers of the A2AR–CB2R heteromer interconverted from TM 6 for apo or agonist‐bound A2AR, blocking CB2R activation, to mainly the TM 1/7 interface for antagonist‐bound A2AR, facilitating the independent opening of intracellular cavities for G protein binding. These novel results shed light on a different type of allosteric mechanism and extend the repertoire of GPCR heteromer signalling.LINKED ARTICLES: This article is part of a themed issue Complexity of GPCR Modulation and Signaling (ERNST). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.14/issuetoc

17 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
Claire Alice de MarchClaire Alice de March
Claire Alice de March
NMNing Ma
Ning Ma
CBChristian B. Billesbølle
Christian B. Billesbølle
JTJeevan Tewari
Jeevan Tewari
CTClaudia Llinas del Torrent
Claudia Llinas del Torrent
HMHiroaki Matsunami
Hiroaki Matsunami
A central challenge in olfaction is understanding how the olfactory system detects and distinguishes odorants with diverse physicochemical properties and molecular configurations. Vertebrate animals perceive odors via G protein-coupled odorant receptors (ORs). In humans, ∼400 ORs enable the sense of smell. The OR family is composed of two major classes: Class I ORs are tuned to carboxylic acids while Class II ORs, representing the vast majority of the human repertoire, respond to a wide variety of odorants. How ORs recognize chemically diverse odorants remains poorly understood. A fundamental bottleneck is the inability to visualize odorant binding to ORs. Here, we uncover fundamental molecular properties of odorant-OR interactions by employing engineered ORs crafted using a consensus protein design strategy. Because such consensus ORs (consORs) are derived from the 17 major subfamilies of human ORs, they provide a template for modeling individual native ORs with high sequence and structural homology. The biochemical tractability of consORs enabled four cryoEM structures of distinct consORs with unique ligand recognition properties. The structure of a Class I consOR, consOR51, showed high structural similarity to the native human receptor OR51E2 and yielded a homology model of a related member of the human OR51 family with high predictive power. Structures of three Class II consORs revealed distinct modes of odorant-binding and activation mechanisms between Class I and Class II ORs. Thus, the structures of consORs lay the groundwork for understanding molecular recognition of odorants by the OR superfamily.

11 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
GNGemma Navarro
Gemma Navarro
MGMarc Gómez-Autet
Marc Gómez-Autet
PMPaula Morales
Paula Morales
JRJoan Biel Rebassa
Joan Biel Rebassa
CTClaudia Llinas del Torrent
Claudia Llinas del Torrent
Rafael FrancoRafael Franco
Rafael Franco
G protein-coupled receptors (GPCRs) exist within a landscape of interconvertible conformational states and in dynamic equilibrium between monomers and higher-order oligomers, both influenced by ligand binding. Here, we have shown that a homobivalent ligand formed by equal chromenopyrazole moieties as pharmacophores, connected by 14 methylene units, can modulate the dynamics of the cannabinoid CB 2 receptor (CB 2 R) homodimerization by simultaneously binding both protomers of the CB 2 R-CB 2 R homodimer. Computational and pharmacological experimentals showed that one of the ligand pharmacophores binds to the orthosteric site of one protomer, and the other pharmacophore to a membrane-oriented pocket between transmembranes 1 and 7 of the partner protomer. This provides unique pharmacological properties, such as increased potency in G i binding and increased recruitment of β-arrestin. Thus, by modulating dimerization dynamics, it may be possible to fine-tune CB 2 R activity with potentially improved therapeutic outcomes. HIGHLIGHTS: A homobivalent ligand of CB 2 R (PM369) modulates the dynamics of receptor homodimerization PM369 binds to the orthosteric site of one protomer and to a complementary, membrane-facing, site of the other protomer PM369 triggers CB 2 R homodimerization via the TM 1/7 interface that provides unique pharmacological properties PM369 potentiates signaling, increased potency in G i binding and increased recruitment of β-arrestin These results highlight new approaches to control GPCR signaling GRAPHICAL